Just a few years ago, children with Type 1 diabetes reported to the school nurse several times a day to get a finger pricked to check whether their blood sugar was dangerously high or low. The introduction of the continuous glucose monitor (CGM) made that unnecessary. The small device, typically attached to the arm, has…
As President Trump begins his second term, the public’s trust in health information from key health agencies has fallen over the past 18 months, continuing a decline that began during the COVID-19 pandemic, finds the new KFF Tracking Poll on Health Information and Trust. Just over half (53%) of the public now says they trust…More
What Is Environmental Services (EVS) in Healthcare? Sometimes referred to as housekeeping or janitorial services, environmental services is a term used exclusively in healthcare to describe the process highly trained support service staff conduct to clean and disinfect medical equipment, patient rooms and other common areas within healthcare facilities. Environmental services prevent infections from spreading…
Chuanzi Yue and Marisa Miraldo argue in a recent Health Affairs Forefront piece that the answer is ‘yes’, but I am highly skeptical of their claim. Will IRA cause firms to allocate funds from marketing to R&D? One point they make is that the IRA’s Medicare Drug Price Negotiation program will reduce pharmaceutical expenses on…
The AI race heats up with a new kid on the block from China. How did it compare against a popular U.S. genAI engine on a simple healthcare industry question? The post DeepSeek v. ChatGPT: Why is healthcare so expensive in America? (Video) appeared first on MedCity News.
Through its partnership with Pelago, Lantern’s clients can access Pelago’s substance use disorder treatment through Lantern’s specialty care platform. The post Lantern Teams Up with Pelago to Expand Access to Substance Use Disorder Treatment appeared first on MedCity News.
Sequoia Project work group co-chairs discuss the state of granular data-sharing consent and some possible approaches to further progress
By EMILY JOHNSON Imagine you’re an executive at a large health system in a major metropolitan area. One morning, you wake up to a missed call and a voicemail from your PR leader. It’s urgent: one of your employees–who was also a patient and a member of the organization–has unexpectedly died by suicide. Their family…
Akero Therapeutics reported that at 96 weeks, 39% of patients who received the 50 mg dose of efruxifermin achieved improvement in fibrosis, or liver scarring, caused by the fatty liver disease MASH. This study previously failed to achieve statistically significant improvement at 36 weeks, but Akero executives say the latest results show that longer dosing…
Surgery centers are the next focus, President and CEO Martin Bonick told a recent industry conference. But that push is more likely to be about building than buying.